Clinical Trial Inspections in India: 483-like Observations
Clinical Trial Inspections in India: 483-like Observations Key Inspection Observations in Indian Clinical Trials: Parallels with FDA 483s Introduction Clinical trial inspections serve as a critical mechanism to assess regulatory compliance, ethical conduct, and data integrity across global trial sites. In India, the Central Drugs Standard Control Organization (CDSCO) and the Drug Controller General of…
Read More “Clinical Trial Inspections in India: 483-like Observations” »